Montreal Cognitive Assessment: Normative Data for Cognitively Healthy Swedish 80- to 94-Year-Olds.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2022
Historique:
pubmed: 19 4 2022
medline: 9 6 2022
entrez: 18 4 2022
Statut: ppublish

Résumé

The Montreal Cognitive Assessment (MoCA) is sensitive to cognitive impairment; however, it is also sensitive to demographic and socio-cultural factors. This necessitates reliable sub-population norms, but these are often lacking for older adults. To present demographically adjusted regression-based MoCA norms for cognitively healthy Swedish older adults. A pseudo-random sample of community-dwelling 80- to 94-year-olds, stratified by age and gender, was invited to the study. Initial telephone interviews and medical records searches (n = 218) were conducted to screen for cognitive impairment. N = 181 eligible participants were administered a protocol including the Swedish version of the MoCA and assessments of global cognition (Mini-Mental State Examination, MMSE) and depression (Patient Health Questionnaire-9, PHQ-9). Individuals scoring in the range of possible cognitive impairment on the MMSE or more than mild depression on the PHQ-9 were excluded (n = 23); three discontinued the test-session. Norms were derived from the remaining n = 158. They were evenly distributed by gender, on average 85 years old, and with a mean education of 11 years. MoCA scores were independently influenced by age and education, together explaining 17.2% of the total variance. Higher age and lower education were associated with lower performance and 46% performed below the original cut-off (< 26/30). The negative impact of increasing age on MoCA performance continues linearly into the nineties in normal aging. Demographic factors should be considered when interpreting MoCA performance and a tool for computing demographically corrected standard scores is provided.

Sections du résumé

BACKGROUND
The Montreal Cognitive Assessment (MoCA) is sensitive to cognitive impairment; however, it is also sensitive to demographic and socio-cultural factors. This necessitates reliable sub-population norms, but these are often lacking for older adults.
OBJECTIVE
To present demographically adjusted regression-based MoCA norms for cognitively healthy Swedish older adults.
METHODS
A pseudo-random sample of community-dwelling 80- to 94-year-olds, stratified by age and gender, was invited to the study. Initial telephone interviews and medical records searches (n = 218) were conducted to screen for cognitive impairment. N = 181 eligible participants were administered a protocol including the Swedish version of the MoCA and assessments of global cognition (Mini-Mental State Examination, MMSE) and depression (Patient Health Questionnaire-9, PHQ-9). Individuals scoring in the range of possible cognitive impairment on the MMSE or more than mild depression on the PHQ-9 were excluded (n = 23); three discontinued the test-session.
RESULTS
Norms were derived from the remaining n = 158. They were evenly distributed by gender, on average 85 years old, and with a mean education of 11 years. MoCA scores were independently influenced by age and education, together explaining 17.2% of the total variance. Higher age and lower education were associated with lower performance and 46% performed below the original cut-off (< 26/30).
CONCLUSION
The negative impact of increasing age on MoCA performance continues linearly into the nineties in normal aging. Demographic factors should be considered when interpreting MoCA performance and a tool for computing demographically corrected standard scores is provided.

Identifiants

pubmed: 35431248
pii: JAD215629
doi: 10.3233/JAD-215629
pmc: PMC9198733
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1335-1344

Références

J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Am J Geriatr Psychiatry. 2018 Dec;26(12):1258-1267
pubmed: 30314940
Int J Geriatr Psychiatry. 2018 Feb;33(2):379-388
pubmed: 28731508
Assessment. 2006 Mar;13(1):62-79
pubmed: 16443719
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(6):755-61
pubmed: 25942388
Ann Intern Med. 1987 Oct;107(4):481-5
pubmed: 3631786
J Alzheimers Dis. 2017;59(3):893-901
pubmed: 28697562
Cochrane Database Syst Rev. 2015 Oct 29;(10):CD010775
pubmed: 26513331
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(4):413-37
pubmed: 25325767
Int J Geriatr Psychiatry. 2009 Feb;24(2):197-201
pubmed: 18850670
Br J Clin Psychol. 2006 Sep;45(Pt 3):393-402
pubmed: 17147104
Arq Neuropsiquiatr. 2019 Nov;77(11):775-781
pubmed: 31826133
Clin Neuropsychol. 2021 Sep 1;:1-16
pubmed: 34470584
Neurol Sci. 2015 Apr;36(4):585-91
pubmed: 25380622
Appl Neuropsychol Adult. 2017 Jan-Feb;24(1):23-29
pubmed: 27144665
J Gerontol. 1982 May;37(3):323-9
pubmed: 7069156
J Clin Exp Neuropsychol. 2011 Nov;33(9):989-96
pubmed: 22082082
J Am Geriatr Soc. 2019 Mar;67(3):534-538
pubmed: 30536796
Neurology. 2011 Sep 27;77(13):1272-5
pubmed: 21917776
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Nat Rev Neurol. 2014 Nov;10(11):634-42
pubmed: 25266297
Neuroepidemiology. 2013;40(1):23-9
pubmed: 23075757
Arch Clin Neuropsychol. 2016 Nov 22;31(7):819-826
pubmed: 27625048
Clin Neuropsychol. 2017 Jan-Dec;31(sup1):1-19
pubmed: 28276861
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Cogn Behav Neurol. 2013 Mar;26(1):1-5
pubmed: 23538566
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2021 Jun 13;:1-20
pubmed: 34121606
Fam Med Community Health. 2020 Feb 16;8(1):e000262
pubmed: 32148735
Int J Geriatr Psychiatry. 2017 Oct;32(10):1085-1093
pubmed: 27593974
Psychiatr Pol. 2016 Oct 31;50(5):1039-1052
pubmed: 27992895
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Geriatr Psychiatry Neurol. 2011 Dec;24(4):184-90
pubmed: 22228824
Alzheimers Dement (Amst). 2016 Jun 29;4:43-6
pubmed: 27489879
J Alzheimers Dis. 2018;64(2):643-655
pubmed: 29945351
Arch Clin Neuropsychol. 2016 May;31(3):246-53
pubmed: 26891720
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Neurocase. 2012;18(4):336-51
pubmed: 22044211
Arch Clin Neuropsychol. 2010 Mar;25(2):126-38
pubmed: 20118110
Aging Clin Exp Res. 2018 Aug;30(8):993-998
pubmed: 29188578

Auteurs

Elisabet Classon (E)

Department of Acute Internal Medicine and Geriatrics, and Department of Health, Medicine and Caring Sciences, Division of Prevention, Rehabilitation and Community Medicine, Linköping University, Linköping, Sweden.

Wobbie van den Hurk (W)

Mindmore AB, Stockholm, Sweden, and Department of Health, Medicine and Caring Sciences, Division of Prevention, Rehabilitation and Community Medicine, Linköping University, Linköping, Sweden.

Johan Lyth (J)

Department of Health, Medicine and Caring Sciences, Division of Society and Health, Linköping University, Linköping, Sweden.

Maria M Johansson (MM)

Department of Activity and Health, and Department of Health, Medicine and Caring Sciences, Division of Prevention, Rehabilitation and Community Medicine, Linköping University, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH